Listing 1 - 10 of 12 | << page >> |
Sort by
|
Choose an application
Cardiology and cardiovascular sciences are two rapidly growing areas in medicine, with heart diseases being the number one cause of death worldwide. The last four decades have witnessed many developments in various cardiological sciences, including coronary artery disease, valve disease, heart failure, congenital heart diseases, and cardiovascular imaging, with a number of newly developed concepts, such as cardio-oncology, cardio-renal diseases, and preventive cardiology. This Special Issue (SI) of the Journal of Clinical Medicine, entitled “JCM-Advances in Cardiology”, focuses on recent advances in the cardiological sciences. It published 8 research articles of significant clinical and scientific value.
ST segment elevation myocardial infarction --- COVID-19 --- primary percutaneous intervention --- Coptic clergy --- mortality --- cardiovascular risk factors --- prevalence --- major adverse events --- obesity --- ACE2 --- renin–angiotensin system --- extraction --- reimplantation --- pacing --- ICD --- CRT --- dilated cardiomyopathy (DCM) --- LMNA --- lamin A --- lamin C --- next generation sequencing (NGS) --- myocarditis --- arrhythmias --- telemonitoring --- implantable cardioverter defibrillator --- implantable loop recorder --- Holter ECG --- metabolic-dysfunction-associated fatty liver disease (MAFLD) --- hepatic steatosis --- SteatoTest --- adipokines --- adiponectin --- visfatin --- cardiovascular disease --- n/a --- renin-angiotensin system
Choose an application
The adipokine adiponectin is very concentrated in plasma, and decreased levels of adiponectin are associated with pathological conditions such as obesity, diabetes, cardiovascular diseases, and metabolic syndrome. When produced in its full-length form, adiponectin self-associates to generate multimeric complexes. The full-length form of adiponectin can be cleaved by the globular form of elastase that is produced locally, and the resulting biological effects are exerted in a paracrine or autocrine manner. The different forms of adiponectin bind to specific receptors consisting of two G-protein-independent, seven-transmembrane-spanning receptors, called AdipoR1 and AdipoR2, while T-cadherin has been identified as a potential receptor for high molecular weight complexes of adiponectin. Adiponectin exerts a key role in cellular metabolism, regulating glucose levels as well as fatty acid breakdown. However, its biological effects are heterogeneous, involving multiple target tissues. The Special Issue “Mechanisms of Adiponectin Action” highlights the pleiotropic role of this hormone through 3 research articles and 7 reviews. These papers focus on the recent knowledge regarding adiponectin in different target tissues, both in healthy and in diseased conditions.
acidic and rich in cysteine (SPARC) --- n/a --- regeneration --- fertility --- pig --- endocrine cancer --- NGF? --- reproductive tract --- neuritogenesis --- skeletal muscle --- matricellular proteins --- adiponectin isoforms --- obesity --- atherosclerosis --- hair growth-related factor --- ovarian cancer --- adipose tissue --- AdipoRon --- extracellular signal-regulated kinase (ERK) --- PC12 cells --- endometrial cancer --- AMPK --- metabolism --- adiponectin --- transcriptome --- exercise --- training --- inflammation --- BIAcore --- muscle --- adipokines --- human follicular dermal papilla cell --- estrogen receptor --- endometrium --- adiponectin inducer --- breast cancer --- implantation --- microarray --- Secreted protein --- adipogenesis --- kojyl cinnamate ester derivative --- cell signaling --- lipotoxicity --- cervix cancer --- cancer --- cholesterol efflux --- myopathies --- diabetes
Choose an application
This book provides a resource for the scientist or medical professional interested in the topic of insulin resistance. With a mix of review and primary data articles, emerging paradigms in insulin resistance are highlighted. The topics are succinctly presented, and distinct viewpoints are represented. An introduction to the Special Issue that provides summaries of the studies included, is provided by the Guest Editor, Dr. Susan Burke, and her colleague at the Pennington Biomedical Research Center, Dr. Jason Collier.
Research & information: general --- Biology, life sciences --- epicardial adipose tissue --- hypertrophy of adipocytes --- CAD severity --- adipokines --- insulin resistance --- insulin-degrading enzyme --- pancreas --- liver --- insulin receptor --- glucose transporters --- acute intermittent porphyria --- carbohydrate loading therapy --- hyperinsulinemia --- fast-acting insulin --- experimental liver-targeted insulin --- hyperinsulinaemia --- osteocalcin --- beta-hydroxybutyrate --- phenotype --- stages --- serotonin --- glucagon-like peptide-1 --- glucagon --- type 2 diabetes --- hyperglycaemia --- apoptosis --- endoplasmic reticulum stress --- glucosamine --- pancreatic β-cell dysfunction --- ovariectomy --- raloxifene --- Negr1 --- obesity --- metabolic disease --- metabolomics --- glucose intolerance --- genetic models --- beta hydroxybutyrate --- osteoporosis --- fragility fractures --- bone mineral density --- osteocalin --- vitamin D --- collagen --- hydroxyapatite --- diabetes --- inflammation --- thiazolidinedione --- n/a
Choose an application
In this book, we have reported the most recent discoveries and updates regarding molecular pathways in osteoarthritis. In particular, the advances regarding therapeutical options, from a molecular point of view, are largely discussed.
osteoarthritis --- cartilage --- type II collagen --- matrix metalloproteinases --- MMP-13 --- regulation --- inhibitor --- NO synthase --- Interleukin-1β --- chondrocytes --- mitochondrial dysfunction --- mesenchimal stem cells --- chondrocytic commitment --- autophagy --- miRNAs --- hydrostatic pressure --- adipokines --- visfatin --- Wnt/β-catenin --- mechanical loading --- obesity --- microRNA --- oxidative stress --- vibrational spectroscopy --- near-infrared spectroscopy --- infrared spectroscopy --- Raman spectroscopy --- early diagnosis --- exercise --- physical activity --- nutraceuticals --- dietary supplements --- inflammation --- aging --- inflammaging --- osteochondral explant culture --- joint modelling --- pharmacological assay --- native tissue analysis --- hexosamine biosynthetic pathway --- cartilage trauma --- post-traumatic osteoarthritis --- O-GlcNAcylation --- glucosamine --- cell death --- therapy --- sex as a biological variable --- whole transcriptome sequencing --- molecules --- TGF-β --- SMAD2/3 signaling --- linker modifications --- meniscus --- proteomics --- MRM --- ECM --- celecoxib --- glucosamine sulfate --- chondroprotection --- NF-κB --- cytokines --- chemokines --- pathogenesis --- biomarker --- chondrocyte --- IL-1β --- IFNγ, IL-17 --- IL-4 --- RNA-Seq --- hypertrophy --- remodeling --- angiogenesis --- chondroitin --- collagen --- methylsulfonylmethane --- vitamin C --- vitamin D --- hyaluronic acid
Choose an application
MicroRNAs (miRs) are small noncoding RNAs that function as post-transcriptional regulators of gene expression and have important roles in almost all biological pathways. Deregulated miR expression has been detected in numerous cancers, where miRs act as both oncogene and tumor suppressors. Due to their important roles in tumorigenesis, miRs have been investigated as prognostic and diagnostic biomarkers and as useful targets for therapeutic intervention. From a therapeutic point of view, two modalities can serve to rectify gene networks in cancer cells. For oncomiRs, a rational means is downregulation through antagomirs. Moreover, observations of the pathological reductions in tumor-suppressive miRs have inspired the concept of “miR replacement therapy” to enhance the amount of these miRs, thereby restoring them to normal levels. However, the clinical applicability of miR-based therapies is severely limited by the lack of effective delivery systems. Therefore, to understand the role of this new class of regulators, we need to identify the mRNA targets regulated by individual miRs as well as to develop specific, efficient, and safe delivery systems for therapeutic miRs.
Breast cancer --- Hypoxia inducible factor 1-alpha (HIF-1α) --- MicroRNA (miRNA) --- miR526b --- miR655 --- Oxidative stress --- Migration --- Cyclooxygenase-2 (COX-2) --- Prostaglandin E2 receptor 4 (EP4) --- PI3K/Akt --- adipokines --- endometrial cancer --- estrogens --- hyperinsulinemia --- insulin --- insulin resistance --- insulin signaling --- insulin-like growth factors --- microRNA --- miRNA --- ovarian cancer --- survival --- prognostic factor --- serum LDH --- blood biomarker --- circulating microRNA --- plasma --- immunotherapy --- immune checkpoint inhibitors --- metastatic melanoma --- hepatocellular carcinoma --- metastasis --- exosome --- bioinformatics analysis --- renal cancer --- RCC --- ccRCC --- meta-analysis --- miRNAs --- normal B-cell development --- B-CLL --- miRNA-transcription factor network --- regulation --- biomarker --- therapy --- prognosis --- diagnosis --- progression --- prediction --- smoking --- non-small cell lung cancer --- methylation --- miR-584-5p --- YKT6 --- snoRNA --- 2′-O-methylation --- pseudouridylation --- malignant melanoma --- cancer stem cell --- stemness --- head and neck squamous cell carcinoma --- colon cancer --- cancer stem cells --- microRNAs --- deformability --- PARP --- replication stress --- targeted therapy --- breast cancer --- circulating biomarkers --- medulloblastoma --- brain tumour --- subgroups --- stem cells --- n/a --- 2'-O-methylation
Choose an application
Phospholipases are a ubiquitous group of enzymes that hydrolyze ester bonds within membrane phospholipids. These enzymes serve multiple biological functions that go far beyond a mere membrane remodeling role in cellular homeostasis; they also play key functions in nutrient digestion and the regulated formation of bioactive lipids involved in cell signaling. It is to the latter function, critical to life, that this book is primarily concerned with. All the chapters are written by renowned experts in the area, and provide forefront information on the role phospholipases in a number of physiological and pathophysiological settings.
inhibitor --- metabolic stability --- α-methylation --- oxoesters --- phospholipase A2 --- adrenic acid --- arachidonic acid --- mass spectrometry --- lipid signaling --- inflammation --- monocytes/macrophages --- crotoxin --- snake venom --- lung impairment --- inflammatory response --- lipid mediators --- neuromuscular blocker --- lipidomics --- PAP-2 --- autotaxin --- lysophosphatidate --- G protein-coupled receptor --- PLA2G6 --- fatty liver --- phospholipid remodeling --- diet-induced obesity --- morbidly obesity --- choline and methionine deficiency --- glioblastoma --- sphingolipid --- sphingosine-1-phosphate --- sphingomyelinase --- sphingomyelin --- metastasis --- phosphatidic acid --- diacylglycerol --- lipin --- signaling --- cPLA2α --- psoriasis --- proliferation --- anti-inflammatory --- atherosclerosis --- phospholipases --- macrophages --- T cells --- lipins --- pancreatic islets --- β-cells --- insulin secretion --- glucose tolerance --- insulin resistance --- group VIA phospholipase A2 --- fatty acid --- knockout mouse --- lipid mediator --- lysophospholipid --- membrane --- phospholipid --- ceramide --- acidic sphingomyelinase --- neutral sphingomyelinase --- hepatocellular carcinoma --- alcoholic and nonalcoholic steatohepatitis --- preadipocytes --- prostaglandins --- adipokines --- cytokines --- EP receptors --- Group V phospholipase A2 --- lipids --- majeed syndrome --- LPIN2 --- LIPIN2 --- chronic non-bacterial osteomyelitis --- chronic recurrent multifocal osteomyelitis --- autoinflammatory --- inflammasome --- macrophage --- osteoclast --- n/a
Choose an application
This Special Issue contributes original research and review articles on the role of new protein, molecular, and genetic markers used for the diagnosis and progression of civilization diseases, as well as biomarkers useful in the monitoring the effects of the implemented treatment.
pharmacogenomics --- NGS variants --- personalized medicine --- FSHR --- personalized drug therapy --- hedgehog-interacting protein --- impaired fasting glucose --- impaired glucose tolerance --- newly diagnosed diabetes --- normal glucose tolerance --- inflammatory bowel disease --- ulcerative colitis --- Crohn’s disease --- extracellular matrix components --- hyaluronan --- inflammatory bowel diseases (IBD) --- Crohn’s disease (CD) --- ulcerative colitis (UC) --- sulfated glycosaminoglycans (sGAG) --- hyaluronan (HA) --- soluble part of syndecan-1 (sCD138) --- microRNA --- cardiovascular disease --- diabetes --- mortality --- antiplatelet therapy --- platelet reactivity --- Let-7e --- miR-126 --- miR-223 --- miR-125a-3p --- CCL11 --- CCL24 --- CCL26 --- CCR3 --- CRC --- adiponectin --- adipokines --- rheumatology --- obesity --- overweight --- case control study --- rheumatoid arthritis --- TNF-α inhibitors --- bone turnover markers --- PINP --- PICP --- NTX-I --- CTX-I --- RANKL/OPG --- ovarian cancer --- interleukin 21 --- interleukin 22 --- lymphocytes --- macrophages --- dendritic cells --- innate lymphoid cells --- breast cancer --- extracellular matrix --- proteins --- tumorigenesis --- tumor microenvironment
Choose an application
Human lactation has evolved to produce a milk composition that is uniquely-designed for the human infant. Not only does human milk optimize infant growth and development, it also provides protection from infection and disease. More recently, the importance of human milk and breastfeeding in the programming of infant health has risen to the fore. Anchoring of infant feeding in the developmental origins of health and disease has led to a resurgence of research focused in this area. Milk composition is highly variable both between and within mothers. Indeed the distinct maternal human milk signature, including its own microbiome, is influenced by environmental factors, such as diet, health, body composition and geographic residence. An understanding of these changes will lead to unravelling the adaptation of milk to the environment and its impact on the infant. In terms of the promotion of breastfeeding, health economics and epidemiology is instrumental in shaping public health policy and identifying barriers to breastfeeding. Further, basic research is imperative in order to design evidence-based interventions to improve both breastfeeding duration and women’s breastfeeding experience.
Cambodia --- milk metabolomics --- galactogogues --- adequate intake --- postnatal outcomes --- cytomegalovirus --- midwifery --- milk synthesis --- chromatography --- protein --- lactoferrin --- human lactation --- ultrasound skinfolds --- breastfed infants --- knowledge --- pregnancy --- casein --- SEA --- maternal factors --- ethnicity --- post-partum distress --- bottle --- composition --- feeding --- co-sleeping --- passive immunity --- glycerophosphocholine --- anthropometrics --- antimicrobial proteins --- professional support --- mothers of preterm infants --- responsive feeding --- lactating women --- peptidomics --- triiodothyronine --- preterm --- mother–infant physical contact --- expressing --- preterm infant --- appetite regulation --- justification of supplementation --- body composition --- zinc supplementation --- antibodies --- antisecretory factor --- proteolysis --- enteral nutrition --- Ecuador --- growth factors --- maternal responsiveness --- maternal wellbeing --- nipple shield --- microbiome --- maternal distress --- sodium --- thyroid --- maternal diet --- thyroxine --- IgA --- caesarean section --- raw breast milk --- colostrum --- fatty acids --- breast milk --- immune cells --- metabolites --- PEA --- premature --- mode of delivery --- endocannabinoids --- lipids --- practice --- fat synthesis --- attitudes --- feeding cues --- infant --- Docosahexaenoic acid --- Arachidonic acid --- GDM --- milk-acquired infections --- zinc deficiency --- ICP-OES --- social support --- infants --- omega-6 fatty acids --- infant health --- HGF --- omega-3 fatty acids --- OEA --- leptin --- milk metabolites --- Canada --- mother–infant interaction --- NMR spectroscopy --- lipidomics --- infection --- breastfeeding support --- prematurity --- phosphocholine --- immunity --- Quito --- sex-specificity --- choline --- paternal role --- inflammation --- docosahexaenoic acid --- partner support --- proximal care --- thyroid antibodies --- adipokines --- calculated daily intakes --- candida --- proton nuclear magnetic resonance --- N-acylethanolamines --- milk intake --- whey --- bioelectrical impedance spectroscopy --- breastfeeding --- n-6 and n-3 polyunsaturated fatty acid --- babywearing --- milk composition --- breastmilk --- obesity --- lactation --- infant growth --- formula supplementation --- early life nutrition --- adiponectin --- milk cells --- potassium --- human milk --- long-chain polyunsaturated fatty acids --- Andean region --- Ireland --- mass spectrometry --- geographical location --- diet --- dietary recommendations --- TGF-? --- ion selective electrode --- plasma zinc --- barriers --- infant feeding --- human milk composition --- Breastfeeding
Choose an application
Arthritis has a high prevalence globally and includes over 100 different types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis, and inflammatory arthritis. The exact etiology of arthritis remains unclear and no cure exists. Anti-inflammatory drugs are commonly used in the treatment of arthritis but are associated with significant side effects. Novel modes of therapy and additional prognostic biomarkers are urgently needed for arthritis patients. This book summarizes and discusses the global picture of the current understanding of arthritis.
receptor activator of nuclear factor ?B --- infliximab --- tripterine --- triptolide --- osteoblast --- tumor necrosis factor-alpha --- synovial cell --- anti-arthritis --- biosimilars --- Epstein-Barr virus --- cytokines --- SOX9 --- parathyroid hormone --- nitric oxide --- rat --- etanercept --- angiogenesis --- glycosylation --- mitogen activated protein kinase --- Th9 lymphocytes --- rheumatoid arthritis --- IL-6 --- clodronate --- bone erosion --- mesenchymal stem cells --- collagen-induced arthritis --- biological --- gene expression --- inflammatory arthritis --- osteoarthritis --- fraxinellone --- nuclear factor kappa B --- messenger RNA --- inflammation --- miRNA --- disease-modifying --- adipokines --- WNT --- glycoprotein 42 --- miR-199a-5p --- proliferation --- next-generation sequencing --- collagen --- osteoarthritis (OA) --- experimental arthritis --- bone morphogenetic protein --- TNF-? --- computational modeling --- basic research --- osteoclast --- therapeutics --- certolizumab pegol --- chondrocytes --- progenitor cells --- adjuvant arthritis --- adalimumab --- triterpenoid --- sclareol --- TNF? --- fibroblast growth factor 2 --- antibodies --- osteoblasts --- molecular pathology --- Th17 --- immunology --- obesity --- visfatin --- articular cartilage --- autoimmune --- biomarkers --- celastrol --- MAPK --- disease pathways --- IL1? --- arthritis --- bioinformatics --- anticitrullinated peptide antibodies --- drug delivery system --- antagonists --- shared epitope --- pathology --- SMA- and MAD-related protein --- small-molecule inhibitor --- transforming growth factor ? --- mice --- golimumab --- spinal fusion --- antirheumatic drug --- early osteoarthritis --- stem cell --- rheumatoid factor --- therapeutic antibody --- bisphosphonate --- osteoclastogenesis --- interleukin --- spondyloarthropathies --- clinical translation --- therapy --- Traditional Chinese medicine --- chemokines --- structure --- cell signaling --- microRNA
Choose an application
Human milk is uniquely tailored to meet infants’ specific nutritional requirements. However, it is more than just “milk”. This dynamic and bioactive fluid allows mother–infant signalling over lactation, guiding the infant in the developmental and physiological processes. It exerts protection and life-long biological effects, playing a crucial role in promoting healthy growth and optimal cognitive development. The latest scientific advances have provided insight into different components of human milk and their dynamic changes over time. However, the complexity of human milk composition and the synergistic mechanisms responsible for its beneficial health effects have not yet been unravelled. Filling this knowledge gap will shed light on the biology of the developing infant and will contribute to the optimization of infant feeding, particularly that of the most vulnerable infants. Greater understanding of human milk will also help in elucidating the best strategies for its storage and handling. The increasing knowledge on human milk’s bioactive compounds together with the rapidly-advancing technological achievements will greatly enhance their use as prophylactic or therapeutic agents. The current Special Issue aims to welcome original works and literature reviews further exploring the complexity of human milk composition, the mechanisms underlying the beneficial effects associated with breastfeeding, and the factors and determinants involved in lactation, including its promotion and support.
high pressure processing --- n/a --- lipids --- supplementation --- protective factors --- infant --- carbohydrate --- mothers --- antioxidant capacity --- protein --- fat --- cytokines --- bioactive factors --- late preterm --- zinc --- infants --- docosahexaenoic acid (DHA) --- pregnancy --- eicosapentaenoic acid (EPA) --- Lipidomics --- magnesium --- omega-3 fatty acids --- vitamin D deficiency --- flow injection analysis --- human milk benefits --- multiple source method --- 3?-sialyllactose (3?SL) --- milk banking --- milk group --- pasteurization --- video instruction --- Milk Fat Globule Membrane --- bile salt stimulated lipase --- breastfeeding difficulties --- breastfeeding support --- prematurity --- carotenoids --- hormones --- phosphocholine --- amino acids --- targeted metabolomics --- high-performance liquid chromatography (HPLC) --- choline --- selenium --- ?-linolenic acid --- arachidonic acid (ARA) --- docosahexaenoic acid --- human milk fortification --- protease inhibitors --- celiac disease --- copper --- term --- adipokines --- iodine --- mammary gland --- nutritional status --- food frequency questionnaire --- neonate --- early breastfeeding cessation --- prospective study --- breastfeeding --- mothers’ own milk --- disialyllacto-N-tetraose (DSLNT) --- country --- lactating women --- undernourishment --- proteases --- preterm --- expressing --- dietary assessment --- retinol --- body composition --- duration of lactation --- passive immunization --- 2?-fucosyllactose (2?FL) --- phosphorus --- clinical trial --- growth factors --- infant formula --- digestive tract --- human milk oligosaccharides (HMO) --- sodium --- nutrition --- eicosapentaenoic acid --- lipid metabolites --- lactation --- nervonic acid --- ?-tocopherol --- macronutrients --- glycoprotein --- term infant --- term infants --- maternal diet --- promotion of breastfeeding --- potassium --- antioxidants --- maternal immunoglobulins --- Human Milk --- human milk --- Phospholipids --- flu vaccine --- lactational stage --- lactose --- storage --- dietary intake --- Preterm infant --- immune-active proteins --- colostrum --- human milk fat --- inadequate intake --- milk therapy --- endogenous peptide --- calcium --- fatty acids --- breast milk --- pumping --- secretor --- LC-MS --- n-9 fatty acid --- Lewis --- donor human milk --- antenatal --- online --- iron --- growth --- donor milk --- mothers' own milk
Listing 1 - 10 of 12 | << page >> |
Sort by
|